Humoral and Cellular Responses to SARS-CoV-2 Vaccines in MS Patients on Ocrelizumab and Other Disease-modifying Therapies: A Prospective Study From NYU Multiple Sclerosis Care Center (P1-1.Virtual)
Year: 2022
Type: article
Study design: Observational Study
Source: Neurology
Authors: Ilya Kister, Yury Patskovsky, Ryan Curtin, Iryna Voloshyna, Katherine Perdomo, Zoe Rimler, Jinglan Pei, Nicole Ferstler, Yogambigai Velmurugu, Samantha Nyovanie, Mark J. Mulligan, Joseph Kim, Ethan Tardio, Tamar Bacon, Lana Zhovtis Ryerson, Marie Samanovic-Golden, Amber Cornelius, Catarina Raposo, Jessica Priest, Ryan C. Winger, Michelle Krogsgaard, Gregg J. Silverman
Institutions: New York University, Genentech, Roche (Switzerland)
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389366557